Although copy number analysis of amplicon‐based NGS approaches is less robust than other approaches, our validation work (Figure S4) and the high ranking of PBX1 in the genome‐wide integrative approach (Figure 4A) prompted us to investigate the role of this protein in CCA. This evidence concerns the gene PBX1 and cholangiocarcinoma.